391 related articles for article (PubMed ID: 19428558)
41. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
Ambrosio AR; De Messias-Reason IJ
Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991
[TBL] [Abstract][Full Text] [Related]
42. Role of mannose binding lectin gene variants on its protein levels and macrophage phagocytosis with live Mycobacterium tuberculosis in pulmonary tuberculosis.
Selvaraj P; Jawahar MS; Rajeswari DN; Alagarasu K; Vidyarani M; Narayanan PR
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):433-7. PubMed ID: 16553818
[TBL] [Abstract][Full Text] [Related]
43. Interactions of ficolin and mannose-binding lectin with fibrinogen/fibrin augment the lectin complement pathway.
Endo Y; Nakazawa N; Iwaki D; Takahashi M; Matsushita M; Fujita T
J Innate Immun; 2010; 2(1):33-42. PubMed ID: 20375621
[TBL] [Abstract][Full Text] [Related]
44. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
[TBL] [Abstract][Full Text] [Related]
45. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity.
Bouwman LH; Roep BO; Roos A
Hum Immunol; 2006; 67(4-5):247-56. PubMed ID: 16720204
[TBL] [Abstract][Full Text] [Related]
46. Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity.
Sorensen GL; Petersen I; Thiel S; Fenger M; Christensen K; Kyvik KO; Sørensen TI; Holmskov U; Jensenius JC
Genet Epidemiol; 2007 Jan; 31(1):31-41. PubMed ID: 17096357
[TBL] [Abstract][Full Text] [Related]
47. The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
Olesen HV; Jensenius JC; Steffensen R; Thiel S; Schiøtz PO
Clin Immunol; 2006 Dec; 121(3):324-31. PubMed ID: 17045845
[TBL] [Abstract][Full Text] [Related]
48. Mannan binding lectin and viral hepatitis.
Brown KS; Ryder SD; Irving WL; Sim RB; Hickling TP
Immunol Lett; 2007 Jan; 108(1):34-44. PubMed ID: 17157924
[TBL] [Abstract][Full Text] [Related]
49. The role of nanometer-scaled ligand patterns in polyvalent binding by large mannan-binding lectin oligomers.
Gjelstrup LC; Kaspersen JD; Behrens MA; Pedersen JS; Thiel S; Kingshott P; Oliveira CL; Thielens NM; Vorup-Jensen T
J Immunol; 2012 Feb; 188(3):1292-306. PubMed ID: 22219330
[TBL] [Abstract][Full Text] [Related]
50. Mannose-binding lectin enhances the attachment and phagocytosis of mycobacteria in vitro.
Bonar A; Chmiela M; Rudnicka W; Rózalska B
Arch Immunol Ther Exp (Warsz); 2005; 53(5):437-41. PubMed ID: 16314827
[TBL] [Abstract][Full Text] [Related]
51. Investigations on the involvement of the lectin pathway of complement activation in anaphylaxis.
Windbichler M; Echtenacher B; Takahashi K; Ezekowitz RA; Schwaeble WJ; Jenseniuis JC; Männel DN
Int Arch Allergy Immunol; 2006; 141(1):11-23. PubMed ID: 16804320
[TBL] [Abstract][Full Text] [Related]
52. Mannan binding lectin and its interaction with immunoglobulins in health and in disease.
Arnold JN; Dwek RA; Rudd PM; Sim RB
Immunol Lett; 2006 Aug; 106(2):103-10. PubMed ID: 16814399
[TBL] [Abstract][Full Text] [Related]
53. The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases.
Teillet F; Dublet B; Andrieu JP; Gaboriaud C; Arlaud GJ; Thielens NM
J Immunol; 2005 Mar; 174(5):2870-7. PubMed ID: 15728497
[TBL] [Abstract][Full Text] [Related]
54. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis.
Hisano S; Matsushita M; Fujita T; Takeshita M; Iwasaki H
Pathol Int; 2007 Jun; 57(6):351-7. PubMed ID: 17539966
[TBL] [Abstract][Full Text] [Related]
55. Recombinant mannan-binding lectin (MBL) for therapy.
Jensenius JC; Jensen PH; McGuire K; Larsen JL; Thiel S
Biochem Soc Trans; 2003 Aug; 31(Pt 4):763-7. PubMed ID: 12887299
[TBL] [Abstract][Full Text] [Related]
56. Mannose-binding lectin genotype and invasive pneumococcal infection.
Moens L; Van Hoeyveld E; Peetermans WE; De Boeck C; Verhaegen J; Bossuyt X
Hum Immunol; 2006 Aug; 67(8):605-11. PubMed ID: 16916656
[TBL] [Abstract][Full Text] [Related]
57. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
[TBL] [Abstract][Full Text] [Related]
58. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
[TBL] [Abstract][Full Text] [Related]
59. Impact of mannose-binding lectin on susceptibility to infectious diseases.
Eisen DP; Minchinton RM
Clin Infect Dis; 2003 Dec; 37(11):1496-505. PubMed ID: 14614673
[TBL] [Abstract][Full Text] [Related]
60. Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults.
Garcia-Laorden MI; Sole-Violan J; Rodriguez de Castro F; Aspa J; Briones ML; Garcia-Saavedra A; Rajas O; Blanquer J; Caballero-Hidalgo A; Marcos-Ramos JA; Hernandez-Lopez J; Rodriguez-Gallego C
J Allergy Clin Immunol; 2008 Aug; 122(2):368-74, 374.e1-2. PubMed ID: 18582923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
